{"id":"W1568498224","doi":"10.1002/cncr.28974","title":"Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML","year":2014,"lang":"en","type":"article","venue":"Cancer","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Cytarabine; Internal medicine; Clinical endpoint; Oncology; Population; Salvage therapy; Regimen; Randomized controlled trial; Chemotherapy regimen; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006652882,0.0002787587,0.001057816,0.0003317044,0.00007809807,0.000011306,0.0001608383,0.000172436,0.0002343941],"category_scores_gemma":[0.00180873,0.0001945549,0.0001853168,0.0004674739,0.0003481501,0.0001503856,0.00005923492,0.0005513187,0.00001323032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006571276,"about_ca_system_score_gemma":0.0003982334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003121868,"about_ca_topic_score_gemma":0.001356018,"domain_scores_codex":[0.9978325,0.0002528868,0.0005806818,0.0004529583,0.0004602204,0.0004207794],"domain_scores_gemma":[0.9976511,0.0007815555,0.0002702211,0.0004883173,0.0006405592,0.0001682219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9797533,0.0008153013,0.0002090448,0.0001275551,0.0002909929,0.00002895459,0.0031575,0.00008022294,0.002576609,0.00001767365,0.001783408,0.01115948],"study_design_scores_gemma":[0.9683113,0.01524878,0.000107834,0.0008872268,0.0001236124,0.000007246778,0.0004380536,0.005666936,0.007059253,0.000007800862,0.001948452,0.0001934735],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923953,0.0006421042,0.0001514318,0.001839501,0.0009033644,0.003487374,0.0000173792,0.00005262272,0.0005109635],"genre_scores_gemma":[0.994691,0.002693831,0.0001763894,0.0005206122,0.0006351961,0.0006225785,0.00004611838,0.00005744342,0.0005568968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01443348,"threshold_uncertainty_score":0.7933719,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01974977082148697,"score_gpt":0.3206287350294617,"score_spread":0.3008789642079747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}